Table 7.
Measurement | Resting exposure | Exercising exposure | Exercise/rest | Reference for exercising exposure |
---|---|---|---|---|
O3minus air | ||||
FEV1 % decrement | ~2 | 10.3* | 5.0 | 1 |
BALF cell 18O | 5.6* | 28.4* | 5.1 | 1 |
BAL surfactant 18O | 26.4* | 51.6* | 2.0 | 1 |
Nasal lavage 18O | 377* | 192* | 0.5 | 1 |
O3/air ratio | ||||
BALF cells recovered, % decrement | 19* | 28* | 1.5 | 1 |
BALF neutrophils, fold increase | 1.52* | 7.6* | 5.0 | 1,2 |
BALF protein, fold increase | 0.99 | 1.9* | 2.0 | 1,2 |
BALF cell phagocytosis (serum opsonized), % decrement | 20* | 23 | 1.2 | 2 |
BALF cell phagocytosis (IgG opsonized ), % decrement | 1 | 26* | 26 | 2 |
BALF cell phagocytosis (unopsonized), % decrement | 24 | 45* | 1.9 | 2 |
BALF IL6, fold increase | 1.1 | 7.3* | 6.9 | 2 |
BALF LDH, fold increase | 1.2 | 1.5* | 1.3 | 2 |
BALF a1-AT, fold increase | 1.1 | 1.7* | 1.5 | 2 |
BALF C3a fold increase | 2.3 | 1.4 | 0.6 | 2 |
Notes:
Significant effect of O3 compared to respective air exposed.
Hatch et al, 1994;
Devlin et al, 1996.